Randomized contorol trial to determine the Efficacy and Safety on suppression of recurrence after suegery with Dinagest or GnRH for endometriosis.

Randomized contorol trial to determine the Efficacy and Safety on suppression of recurrence after suegery with Dinagest or GnRH for endometriosis. - Study of relapse control with genogest after opreration of endometriosis

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000006891

Enrollment

160

Registered

2012-01-01

Start date

2011-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endometriosis

Interventions

Treatment to the postsurgical patient with the endometriosis by genogest in the relapse prevention purpose Treatment to the postsurgical patient with the endometriosis by GnRHa in the relapse prevent

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: (a) Those who will do preserved operation for the endometriosis. (b) Those who signed informed consent. (c) Those who can do non-hormonal contraception for the examination period.

Exclusion criteria

Exclusion criteria: (a) Those who have an abnormal genital hemorrhage which is not diagnosed. (b) The pregnant or lactational woman. (c) Those who have had the side effect in the medicine made of GnRH or Genogest. (d) Those who are judged improper by the researcher or the doctor.

Design outcomes

Primary

Measure	Time frame
Pain relapse rate after the operation	—

Secondary

Measure	Time frame
Efficacy evaluation by objective opinion Efficacy evaluation by change rate of VAS after the operation Evaluation of QOL Evaluation of safety	—

Countries

Japan

Contacts

Public ContactMaki Hyodo

Hiroshima University Hospital Obstetrics and Gynecology

082-257-5262

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026